A new vaccine reportedly helps protect unborn babies from RSV (respiratory syncytial virus).
The vaccine, called Abrysvo, is available now at Kaiser Permanente to patients between the 32nd week and the end of the 36th week of pregnancy.
According to the Centers for Disease Control and Prevention (CDC), it takes two weeks for the body to develop antibodies after vaccination and for those antibodies to be passed on to the baby.
"What it does do is give the baby's immune system great tools to fight against the virus itself and if it mutates the baby immune system will have better tools," said Shilpa Mathew, an obstetrics and gynecology doctor at Kaiser Permanete .
Dr. Mathew went on to say that the most common side effects in expectant mothers is headache, injection-site pain and muscle pain.
